The global heart beat irregularity detection device market is forecasted to expand at 4.5% CAGR to reach a market valuation of US$ 20.7 Million by the end of 2033, up from US$ 12.8 Million that was recorded for 2022.
The market for heart beat irregularity detection devices is expected to be driven by rising incidences of cardiac arrhythmia that call for early identification for optimal care of heart patients.
| Attributes | Details |
|---|---|
| Heart Beat Irregularity Detection Device Market Size (2023) | US$ 13.4 Million |
| Forecasted Market Value (2033) | US$ 20.7 Million |
| Value CAGR (2023 to 2033) | 4.5% |
| Collective Value Share: Top 5 Countries (2022) | 55.4% |
| Key Market Players | Alive Cor, Applied Cardiac Systems, Biotronik, Biotricity, GE Healthcare, iRhythm Technologies, Koninklijke Philips N.V., Medtronic plc., Nihon Kohden Corporation, St. Jude Medical (Abbott Laboratories), Welch Allyn (Hillrom Services, Inc.), NUUBO Smart Solutions Technologies, SL, Spacelabs Healthcare, Inc. (OSI Systems, Inc.), Fukuda Denshi Co., Ltd., Schiller AG, Mortara Instrument Inc., BPL Medical Technologies, and Lepu Medical Technology(Beijing) Co.,Ltd |
Heart beat irregularity detection devices are used for detection for heartbeats, and refers to the techniques used by doctors to determine the type and origin of abnormal cardiac rhythms.
Arrhythmias, which are deviations from the heart's regular rhythm or speed, can be divided into different groups based on where in the heart they occur. The left or right atrium, one of the two upper chambers of the heart, might have an atrial or supraventricular arrhythmia. The lower chambers of the heart, the ventricles, are the genesis of ventricular arrhythmias, which can impair the heart's capacity to pump blood to the body.
The mainly used device by the physicians within the global market is electrocardiogram (ECG).
According to Future Market Insights, the global market has huge growth potential due to the growing incidence of cardiovascular diseases.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for heart beat irregularity detection devices expanded at a CAGR of 5.4% during the historic period (2017 to 2022) and reached a market value of US$ 12.8 Million in 2022.
Arrhythmia refers to an irregular heartbeat. In case of arrhythmia, the heart may beat faster or slower than it would in the absence of one. The heart may beat erratically due to a variety of issues, and the cause will decide the best course of treatment.
Symptoms of cardiac arrhythmia include palpitation, hammering in the chest, dizziness, weakness, weariness, chest tightness, weakening of the heart muscle, and poor ejection fraction.
Some of the reasons of cardiac arrhythmia include coronary artery disease, high blood pressure, irritable tissue in the heart, valve abnormalities, healing process after surgery, changes in heart muscle, and injuries following a heart attack.
The global market is predicted to expand 1.5X its current size by the end of 2033.
| Market Statistics | Details |
|---|---|
| Jan - Jun (H1), 2021 (A) | 3.89% |
| Jul - Dec (H2), 2021 (A) | 4.88% |
| Jan - Jun (H1),2022 Projected (P) | 3.83% |
| Jan - Jun (H1),2022 Outlook (O) | 4.02% |
| Jul - Dec (H2), 2022 Outlook (O) | 4.98% |
| Jul - Dec (H2), 2022 Projected (P) | 4.70% |
| Jan - Jun (H1), 2023 Projected (P) | 4.06% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | 20↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | 13↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | 27↑ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | 9↑ |
Principal Consultant
Medical professionals and consumers are concerned about security weaknesses in medical devices, notably cardiac implanted electronic devices (CIED). Up to 750,000 Medtronic PLC cardiac devices contained a severe cybersecurity flaw in 2019, allowing an attacker with insider knowledge to injure the patient by modifying the programming of an advanced implantable defibrillator.
A shortage of qualified specialists, as well as the detrimental impact of some heart beat irregularity detection devices on patients, are some of the reasons impeding the growth of the heart beat irregularity detection market.
According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of mortality globally, and approximately 30 Million individuals experience a heart attack or stroke each year. Family history, age, cigarette smoking, hypertension, high cholesterol, obesity, physical inactivity, diabetes, poor diets, and excessive alcohol consumption are just a few risk factors that might lead to CVD.
According to the American Heart Association, more than 130 Million Americans are expected to have CVD by 2035, accounting for over half of all adult Americans. People with severe CVD need to be regularly monitored to prevent abrupt heart failure since they are more likely to experience cardiac arrhythmias including tachycardia and bradycardia. The majority of CVDs can be prevented through pre-monitoring and pre-diagnosis. This is the primary factor stimulating the market for heart beat irregularity detection devices.
Recent advancements in HIPPA-compliant technology have enabled safe data transfer without interruptions during the monitoring time for heartbeat detection devices. Innovative new technologies also offer efficient substitutes for conventional Holter monitors that generate alarms for patients with high cardiac arrhythmia risk.
Because of this, the long-term paired with uninterrupted cardiac rhythm control capabilities of such devices may have a beneficial impact on market growth. Through a collaboration with Access Physician, Cuero Regional Hospital, introduced TeleCardiology services in January 2019. These factors are also anticipated to spur the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | The United States |
|---|---|
| Market Share (2023) | 29.5% |
| Market Share (2033) | 28.9% |
| BPS Analysis | -59 |
| Country | China |
|---|---|
| Market Share (2023) | 9.5% |
| Market Share (2033) | 10.2% |
| BPS Analysis | 69 |
| Country | Germany |
|---|---|
| Market Share (2023) | 6.8% |
| Market Share (2033) | 7.3% |
| BPS Analysis | 43 |
| Country | France |
|---|---|
| Market Share (2023) | 5.2% |
| Market Share (2033) | 5.0% |
| BPS Analysis | -20 |
| Country | India |
|---|---|
| Market Share (2023) | 4.6% |
| Market Share (2033) | 4.4% |
| BPS Analysis | -18 |
The United States is set to hold a share of around 29.5% of the global market in 2023. The regional growth is attributed to expanding use of cutting-edge cardiovascular technologies and sophisticated healthcare infrastructure.
By 2030, 12.1 Million Americans are expected to suffer atrial fibrillation, according to the Centers for Disease Control and Prevention (CDC). Such figures suggest that the need for heart beat irregularity detection devices is anticipated to expand, consequently contributing to the market's growth, as AFib is the most prevalent kind of cardiac arrhythmia detected among the patient population in the region.
Germany is set to hold a share of 5.2% of the global market in 2023.
The prevalence of cardiovascular disorders is rising, and there is a growing preference for minimally invasive procedures, which is actively affecting the market's expansion.
According to estimates from the German Heart Surgery Report 2021, 36,714 heart valve treatments and 19,490 procedures involving pacemakers and ICDs was done as part of the estimated 161,261 cardiac procedures in Germany in 2021. The demand for heart beat irregularity detection devices in Germany is rising as a result of the large number of cardiac surgeries.
China is set to hold 9.5% revenue share within the global market space in 2023.
The market for heart beat irregularity detection devices is driven by an increase in the prevalence of cardiovascular diseases, an ageing population that is more prone to coronary heart disease, technological advancements in cardiac monitoring devices that reduce the risk of infection, and increased device effectiveness.
One of the primary underlying causes of heart disease and lung cancer is smoking. The WHO estimates that smoking contributes to over 1 Million cardiovascular deaths in the Asia-Pacific area each year. Smoking causes more than 1 in 5 cardiovascular diseases, including heart attack and stroke.
Electrocardiogram devices are expected to hold a market share of 42.0% in 2023. An ECG records the electrical activity of the heart. It is a painless routine test that is used to quickly discover cardiac abnormalities and keep track of the heart's health; this benefit is likely to fuel the segment's expansion.
The device may be used during chest pain, rapid pulse, heart palpitations, weakness, fatigue, and other, to determine irregular heart rhythms also known as arrhythmias, previous heart attacks, how the pacemaker are working, is blocked or narrowed arteries in the heart are causing chest pain or a heart attack.
Technological developments in this devices such as portable EKG is also the reason behind segment growth. This portable device is small in size and weight, and is simple to operate that transmits data in real time phones and computers.
As per the applications the market has been segmented into tachycardia, bradycardia, premature contractions, and others, in which tachycardia is expected to hold a market share of 30.1% in 2023. Tachycardia is further segmented into atrial tachycardia and ventricular tachycardia.
In the upcoming years, it is anticipated that there will be a rise in the use of technologically improved devices for disease monitoring.
A thorough course of treatment is necessary for atrial tachycardia, a kind of supraventricular tachycardia, to improve outcomes. Devices that can detect abnormal heartbeats are very important for improving disease diagnosis and therapy. Consequently, it is anticipated that the increasing risk of tachycardia would increase the market growth.
The hospitals and clinic segment is set to hold 36.8% revenue share in 2023 globally. The significant share of this market is attributed to factors like the rising incidence of CVD, the rising number of diagnostic hospital patient visits, and the rising number of cardiac implant surgeries. According to the American Heart Association, arrhythmias affect more than 4 Million people and cause close to half a Million fatalities annually in the United States.
Technology and medicine are now integrated, and the twenty-first century has witnessed the introduction of previously bulky, single-function gadgets to a transportable, portable, and multipurpose platform. There has been a shift in the last ten years towards handheld ECG tracking systems that are more compact and portable. Within a hospital or clinic or between patient rooms on a cart for mobility, these gadgets can be easily accommodated, this benefits of the devices with increasing adoption is anticipated to boost the segment growth.
In order to compete in the global heart beat irregularity detection device market, well-known manufacturers who produce and provide cardiac arrhythmia monitoring devices concentrate on releasing improved products. In order to increase their consumer base, these companies are now engaging in strategic alliances with important players in neighboring countries and local companies.
A novel strategy used by manufacturers to increase patient and healthcare professional interest in the device that detects heartbeat is the incorporation of digital software.
Recent Market Developments
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the heart beat irregularity detection device space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value, and Units for Volume |
| Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Distribution Channel, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
Alive Cor and GE Healthcare are the key manufacturers in the global market.
The market is forecast to register a CAGR of 4.5% through 2033.
From 2018 to 2022, the market registered a CAGR of 5.4%.
Rising early detection of optimal care is driving global market opportunities.
The global market size is to reach US$ 20.7 billion by 2033.
1. Executive Summary | Heart Beat Irregularity Detection Device Market 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Disease Epidemiology 4.2. Product Adoption Analysis 4.3. Regulatory Scenario 4.4. Reimbursement Landscape 4.5. PESTEL Analysis 4.6. Porter’s Analysis 4.7. Value Chain Analysis 4.8. Technology Assessment 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare GDP Growth Outlook 5.1.3. Global Cardiac Arrhythmia Monitoring Devices Market Overview 5.2. Forecast Factors - Relevance & Impact 5.2.1. Growing Cases of Cardiac Disorders 5.2.2. Product Launch Activities 5.2.3. Technology Assessment 5.2.4. Reimbursement Scenario 5.2.5. Increased Adoption of Low Cost ECG Services 5.2.6. Growing Adoption of Continuous Patient Monitoring 5.2.7. Rising Disposable Income 5.2.8. Strategic Collaborations among Players 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Crisis Analysis 6.1. COVID-19 and Impact Analysis 6.1.1. By Device 6.1.2. By Application 6.1.3. By End User 6.1.4. By Region 6.2. 2022 Market Scenario 7. Global Market Volume (Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Volume (Units) Analysis, 2017 to 2022 7.2. Current and Future Market Volume (Units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Device 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2032 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Device 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Device, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Device, 2023 to 2033 10.3.1. Holter Monitor 10.3.2. Event Recorder 10.3.3. Mobile Cardiac Telemetry 10.3.4. Implantable Cardiac Monitor 10.3.5. Electrocardiogram 10.3.6. Others 10.4. Market Attractiveness Analysis By Device 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis, By Application, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 11.3.1. Tachycardia 11.3.1.1. Atrial Tachycardia 11.3.1.2. Ventricular Tachycardia 11.3.2. Bradycardia 11.3.3. Premature Contraction 11.3.4. Others 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by End-User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis, By End-User, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2023 to 2033 12.3.1. Hospitals and Clinics 12.3.2. Diagnostic Centers 12.3.3. Ambulatory Surgical Centers 12.3.4. Homecare Settings 12.3.5. Others 12.4. Market Attractiveness Analysis By End-User 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022 13.3. Current Market and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 14.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. The USA 14.4.1.2. Canada 14.4.2. By Device 14.4.3. By Application 14.4.4. By End-User 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Device 14.5.3. By Application 14.5.4. By End-User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 14.9. Country Level Analysis & Forecast 14.9.1. USA Market Analysis 14.9.1.1. Introduction 14.9.1.2. Market Analysis and Forecast by Market Taxonomy 14.9.1.2.1. By Device 14.9.1.2.2. By Application 14.9.1.2.3. By End-User 14.9.2. Canada Market Analysis 14.9.2.1. Introduction 14.9.2.2. Market Analysis and Forecast by Market Taxonomy 14.9.2.2.1. By Device 14.9.2.2.2. By Application 14.9.2.2.3. By End-User 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 15.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. Mexico 15.4.1.2. Brazil 15.4.1.3. Argentina 15.4.1.4. Rest of Latin America 15.4.2. By Device 15.4.3. By Application 15.4.4. By End-User 15.5. By End-User Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Device 15.5.3. By Application 15.5.4. By End-User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 15.9. Country Level Analysis & Forecast 15.9.1. Mexico Market Analysis 15.9.1.1. Introduction 15.9.1.2. Market Analysis and Forecast by Market Taxonomy 15.9.1.2.1. By Device 15.9.1.2.2. By Application 15.9.1.2.3. By End-User 15.9.2. Brazil Market Analysis 15.9.2.1. Introduction 15.9.2.2. Market Analysis and Forecast by Market Taxonomy 15.9.2.2.1. By Device 15.9.2.2.2. By Application 15.9.2.2.3. By End-User 15.9.3. Argentina Market Analysis 15.9.3.1. Introduction 15.9.3.2. Market Analysis and Forecast by Market Taxonomy 15.9.3.2.1. By Device 15.9.3.2.2. By Application 15.9.3.2.3. By End-User 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. Germany 16.4.1.2. Italy 16.4.1.3. France 16.4.1.4. United Kingdom 16.4.1.5. Spain 16.4.1.6. BENELUX 16.4.1.7. Russia 16.4.1.8. Rest of Europe 16.4.2. By Device 16.4.3. By Application 16.4.4. By End-User 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Device 16.5.3. By Application 16.5.4. By End-User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 16.9. Country Level Analysis & Forecast 16.9.1. Germany Market Analysis 16.9.1.1. Introduction 16.9.1.2. Market Analysis and Forecast by Market Taxonomy 16.9.1.2.1. By Device 16.9.1.2.2. By Application 16.9.1.2.3. By End-User 16.9.2. Italy Market Analysis 16.9.2.1. Introduction 16.9.2.2. Market Analysis and Forecast by Market Taxonomy 16.9.2.2.1. By Device 16.9.2.2.2. By Application 16.9.2.2.3. By End-User 16.9.3. France Market Analysis 16.9.3.1. Introduction 16.9.3.2. Market Analysis and Forecast by Market Taxonomy 16.9.3.2.1. By Device 16.9.3.2.2. By Application 16.9.3.2.3. By End-User 16.9.4. United Kingdom Market Analysis 16.9.4.1. Introduction 16.9.4.2. Market Analysis and Forecast by Market Taxonomy 16.9.4.2.1. By Device 16.9.4.2.2. By Application 16.9.4.2.3. By End-User 16.9.5. Spain Market Analysis 16.9.5.1. Introduction 16.9.5.2. Market Analysis and Forecast by Market Taxonomy 16.9.5.2.1. By Device 16.9.5.2.2. By Application 16.9.5.2.3. By End-User 16.9.6. BENELUX Market Analysis 16.9.6.1. Introduction 16.9.6.2. Market Analysis and Forecast by Market Taxonomy 16.9.6.2.1. By Device 16.9.6.2.2. By Application 16.9.6.2.3. By End-User 16.9.7. Russia Market Analysis 16.9.7.1. Introduction 16.9.7.2. Market Analysis and Forecast by Market Taxonomy 16.9.7.2.1. By Device 16.9.7.2.2. By Application 16.9.7.2.3. By End-User 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.4.1. By Country 17.4.1.1. India 17.4.1.2. Indonesia 17.4.1.3. Malaysia 17.4.1.4. Thailand 17.4.1.5. Rest of South Asia 17.4.2. By Device 17.4.3. By Application 17.4.4. By End-User 17.5. Market Attractiveness Analysis 17.5.1. By Country 17.5.2. By Device 17.5.3. By Application 17.5.4. By End-User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 17.9. Country Level Analysis & Forecast 17.9.1. India Market Analysis 17.9.1.1. Introduction 17.9.1.2. Market Analysis and Forecast by Market Taxonomy 17.9.1.2.1. By Device 17.9.1.2.2. By Application 17.9.1.2.3. By End-User 17.9.2. Indonesia Market Analysis 17.9.2.1. Introduction 17.9.2.2. Market Analysis and Forecast by Market Taxonomy 17.9.2.2.1. By Device 17.9.2.2.2. By Application 17.9.2.2.3. By End-User 17.9.3. Malaysia Market Analysis 17.9.3.1. Introduction 17.9.3.2. Market Analysis and Forecast by Market Taxonomy 17.9.3.2.1. By Device 17.9.3.2.2. By Application 17.9.3.2.3. By End-User 17.9.4. Thailand Market Analysis 17.9.4.1. Introduction 17.9.4.2. Market Analysis and Forecast by Market Taxonomy 17.9.4.2.1. By Device 17.9.4.2.2. By Application 17.9.4.2.3. By End-User 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 18.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.4.1. By Country 18.4.1.1. China 18.4.1.2. Japan 18.4.1.3. South Korea 18.4.2. By Device 18.4.3. By Application 18.4.4. By End-User 18.5. Market Attractiveness Analysis 18.5.1. By Country 18.5.2. By Device 18.5.3. By Application 18.5.4. By End-User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 18.9. Country Level Analysis & Forecast 18.9.1. China Market Analysis 18.9.1.1. Introduction 18.9.1.2. Market Analysis and Forecast by Market Taxonomy 18.9.1.2.1. By Device 18.9.1.2.2. By Application 18.9.1.2.3. By End-User 18.9.2. Japan Market Analysis 18.9.2.1. Introduction 18.9.2.2. Market Analysis and Forecast by Market Taxonomy 18.9.2.2.1. By Device 18.9.2.2.2. By Application 18.9.2.2.3. By End-User 18.9.3. South Korea Market Analysis 18.9.3.1. Introduction 18.9.3.2. Market Analysis and Forecast by Market Taxonomy 18.9.3.2.1. By Device 18.9.3.2.2. By Application 18.9.3.2.3. By End-User 19. Oceania Market 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 19.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.4.1. By Country 19.4.1.1. Australia 19.4.1.2. New Zealand 19.4.2. By Device 19.4.3. By Application 19.4.4. By End-User 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Device 19.5.3. By Application 19.5.4. By End-User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 19.9. Country Level Analysis & Forecast 19.9.1. Australia Market Analysis 19.9.1.1. Introduction 19.9.1.2. Market Analysis and Forecast by Market Taxonomy 19.9.1.2.1. By Device 19.9.1.2.2. By Application 19.9.1.2.3. By End-User 19.9.2. New Zealand Market Analysis 19.9.2.1. Introduction 19.9.2.2. Market Analysis and Forecast by Market Taxonomy 19.9.2.2.1. By Device 19.9.2.2.2. By Application 19.9.2.2.3. By End-User 20. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 20.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.4.1. By Country 20.4.1.1. GCC Countries 20.4.1.2. Türkiye 20.4.1.3. South Africa 20.4.1.4. North Africa 20.4.1.5. Rest of Middle East and Africa 20.4.2. By Device 20.4.3. By Application 20.4.4. By End-User 20.5. Market Attractiveness Analysis 20.5.1. By Country 20.5.2. By Device 20.5.3. By Application 20.5.4. By End-User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 20.9. Country Level Analysis & Forecast 20.9.1. GCC Countries Market Analysis 20.9.1.1. Introduction 20.9.1.2. Market Analysis and Forecast by Market Taxonomy 20.9.1.2.1. By Device 20.9.1.2.2. By Application 20.9.1.2.3. By End-User 20.9.2. Türkiye Market Analysis 20.9.2.1. Introduction 20.9.2.2. Market Analysis and Forecast by Market Taxonomy 20.9.2.2.1. By Device 20.9.2.2.2. By Application 20.9.2.2.3. By End-User 20.9.3. South Africa Market Analysis 20.9.3.1. Introduction 20.9.3.2. Market Analysis and Forecast by Market Taxonomy 20.9.3.2.1. By Device 20.9.3.2.2. By Application 20.9.3.2.3. By End-User 20.9.4. North Africa Market Analysis 20.9.4.1. Introduction 20.9.4.2. Market Analysis and Forecast by Market Taxonomy 20.9.4.2.1. By Device 20.9.4.2.2. By Application 20.9.4.2.3. By End-User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Alive Cor 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Sales Footprint 22.3.1.4. SWOT Analysis 22.3.1.5. Key Financials 22.3.1.6. Strategy Overview 22.3.2. Applied Cardiac Systems 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Sales Footprint 22.3.2.4. SWOT Analysis 22.3.2.5. Key Financials 22.3.2.6. Strategy Overview 22.3.3. Biotronik 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Sales Footprint 22.3.3.4. SWOT Analysis 22.3.3.5. Key Financials 22.3.3.6. Strategy Overview 22.3.4. Biotricity 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Sales Footprint 22.3.4.4. SWOT Analysis 22.3.4.5. Key Financials 22.3.4.6. Strategy Overview 22.3.5. GE Healthcare 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Sales Footprint 22.3.5.4. SWOT Analysis 22.3.5.5. Key Financials 22.3.5.6. Strategy Overview 22.3.6. iRhythm Technologies 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Sales Footprint 22.3.6.4. SWOT Analysis 22.3.6.5. Key Financials 22.3.6.6. Strategy Overview 22.3.7. Koninklijke Philips N.V. 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Sales Footprint 22.3.7.4. SWOT Analysis 22.3.7.5. Key Financials 22.3.7.6. Strategy Overview 22.3.8. Medtronic plc. 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Sales Footprint 22.3.8.4. SWOT Analysis 22.3.8.5. Key Financials 22.3.8.6. Strategy Overview 22.3.9. Nihon Kohden Corporation 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Sales Footprint 22.3.9.4. SWOT Analysis 22.3.9.5. Key Financials 22.3.9.6. Strategy Overview 22.3.10. St. Jude Medical (Abbott Laboratories) 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Sales Footprint 22.3.10.4. SWOT Analysis 22.3.10.5. Key Financials 22.3.10.6. Strategy Overview 22.3.11. Welch Allyn (Hillrom Services, Inc.) 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Sales Footprint 22.3.11.4. SWOT Analysis 22.3.11.5. Key Financials 22.3.11.6. Strategy Overview 22.3.12. NUUBO Smart Solutions Technologies, SL 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Sales Footprint 22.3.12.4. SWOT Analysis 22.3.12.5. Key Financials 22.3.12.6. Strategy Overview 22.3.13. Spacelabs Healthcare, Inc. (OSI Systems, Inc.) 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Sales Footprint 22.3.13.4. SWOT Analysis 22.3.13.5. Key Financials 22.3.13.6. Strategy Overview 22.3.14. Fukuda Denshi Co., Ltd. 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Sales Footprint 22.3.14.4. SWOT Analysis 22.3.14.5. Key Financials 22.3.14.6. Strategy Overview 22.3.15. Schiller AG 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Sales Footprint 22.3.15.4. SWOT Analysis 22.3.15.5. Key Financials 22.3.15.6. Strategy Overview 22.3.16. Mortara Instrument Inc. 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Sales Footprint 22.3.16.4. SWOT Analysis 22.3.16.5. Key Financials 22.3.16.6. Strategy Overview 22.3.17. BPL Medical Technologies 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Sales Footprint 22.3.17.4. SWOT Analysis 22.3.17.5. Key Financials 22.3.17.6. Strategy Overview 22.3.18. Lepu Medical Technology(Beijing)Co.,Ltd 22.3.18.1. Overview 22.3.18.2. Product Portfolio 22.3.18.3. Sales Footprint 22.3.18.4. SWOT Analysis 22.3.18.5. Key Financials 22.3.18.6. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Heart Beat Irregularity Detection Device Market
